Free Trial
NYSE:CNMD

CONMED (CNMD) Stock Price, News & Analysis

CONMED logo
$52.94 -1.11 (-2.05%)
Closing price 09/12/2025 03:59 PM Eastern
Extended Trading
$52.90 -0.05 (-0.09%)
As of 09/12/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About CONMED Stock (NYSE:CNMD)

Key Stats

Today's Range
$52.84
$53.88
50-Day Range
$47.62
$55.85
52-Week Range
$46.00
$78.19
Volume
192,700 shs
Average Volume
313,021 shs
Market Capitalization
$1.64 billion
P/E Ratio
15.00
Dividend Yield
1.51%
Price Target
$59.80
Consensus Rating
Hold

Company Overview

CONMED Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

CNMD MarketRank™: 

CONMED scored higher than 82% of companies evaluated by MarketBeat, and ranked 202nd out of 958 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CONMED has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.

  • Upside Potential

    CONMED has a consensus price target of $59.80, representing about 12.9% upside from its current price of $52.94.

  • Amount of Analyst Coverage

    CONMED has only been the subject of 1 research reports in the past 90 days.

  • Read more about CONMED's stock forecast and price target.
  • Earnings Growth

    Earnings for CONMED are expected to grow by 16.55% in the coming year, from $4.35 to $5.07 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CONMED is 15.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 280.42.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CONMED is 15.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 74.52.

  • Price to Earnings Growth Ratio

    CONMED has a PEG Ratio of 1.84. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    CONMED has a P/B Ratio of 1.70. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about CONMED's valuation and earnings.
  • Percentage of Shares Shorted

    6.97% of the float of CONMED has been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in CONMED has recently increased by 5.56%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    CONMED pays a meaningful dividend of 1.51%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    CONMED does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of CONMED is 22.66%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, CONMED will have a dividend payout ratio of 15.78% next year. This indicates that CONMED will be able to sustain or increase its dividend.

  • Read more about CONMED's dividend.
  • Percentage of Shares Shorted

    6.97% of the float of CONMED has been sold short.
  • Short Interest Ratio / Days to Cover

    CONMED has a short interest ratio ("days to cover") of 4.6.
  • Change versus previous month

    Short interest in CONMED has recently increased by 5.56%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    CONMED has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.93 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for CONMED this week, compared to 5 articles on an average week.
  • MarketBeat Follows

    1 people have added CONMED to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CONMED insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.10% of the stock of CONMED is held by insiders.

  • Read more about CONMED's insider trading history.
Receive CNMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CONMED and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNMD Stock News Headlines

2 Reasons CNMD is Risky and 1 Stock to Buy Instead
CONMED (NYSE:CNMD) Could Be A Buy For Its Upcoming Dividend
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Conmed Appoints Kim Kelderman to Board of Directors
See More Headlines

CNMD Stock Analysis - Frequently Asked Questions

CONMED's stock was trading at $68.44 on January 1st, 2025. Since then, CNMD shares have decreased by 22.6% and is now trading at $52.9440.

CONMED Corporation (NYSE:CNMD) released its quarterly earnings data on Wednesday, July, 30th. The company reported $1.15 EPS for the quarter, beating the consensus estimate of $1.13 by $0.02. The company's quarterly revenue was up 3.1% compared to the same quarter last year.
Read the conference call transcript
.

CONMED's top institutional shareholders include Westwood Holdings Group Inc. (4.00%), Westwood Holdings Group Inc. (4.00%), Champlain Investment Partners LLC (2.70%) and Geode Capital Management LLC (2.37%). Insiders that own company stock include Charles Farkas, Daniel S Jonas, Pat Beyer, Brian Concannon, Curt R Hartman, Martha Goldberg Aronson, Peter K Shagory, Barbara J Schwarzentraub, Johonna Marie Pelletier, John D Ferrell, Stanley W Peters III, Todd W Garner and Richard Glaze.
View institutional ownership trends
.

Shares of CNMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CONMED investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 7/3 Dividend
6/13/2025
Ex-Dividend for 7/3 Dividend
6/13/2025
Dividend Payable
7/03/2025
Last Earnings
7/30/2025
Today
9/13/2025
Record date for 10/3 Dividend
9/15/2025
Ex-Dividend for 10/3 Dividend
9/15/2025
Dividend Payable
10/03/2025
Next Earnings (Estimated)
10/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Medical Equipment
Current Symbol
NYSE:CNMD
CIK
816956
Employees
3,900
Year Founded
N/A

Price Target and Rating

High Price Target
$68.00
Low Price Target
$55.00
Potential Upside/Downside
+12.9%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.53
Trailing P/E Ratio
15.00
Forward P/E Ratio
12.17
P/E Growth
1.84
Net Income
$132.42 million
Net Margins
8.31%
Pretax Margin
10.38%
Return on Equity
14.43%
Return on Assets
6.05%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
2.23
Quick Ratio
1.00

Sales & Book Value

Annual Sales
$1.33 billion
Price / Sales
1.24
Cash Flow
$6.58 per share
Price / Cash Flow
8.05
Book Value
$31.16 per share
Price / Book
1.70

Miscellaneous

Outstanding Shares
30,955,000
Free Float
29,995,000
Market Cap
$1.64 billion
Optionable
Optionable
Beta
1.18

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:CNMD) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners